CID 129073603

Pralsetinib

Structural Information

Molecular Formula
C27H32FN9O2
SMILES
CC1=CC(=NN1)NC2=NC(=NC(=C2)C)C3CCC(CC3)(C(=O)N[C@@H](C)C4=CN=C(C=C4)N5C=C(C=N5)F)OC
InChI
InChI=1S/C27H32FN9O2/c1-16-11-22(33-23-12-17(2)35-36-23)34-25(31-16)19-7-9-27(39-4,10-8-19)26(38)32-18(3)20-5-6-24(29-13-20)37-15-21(28)14-30-37/h5-6,11-15,18-19H,7-10H2,1-4H3,(H,32,38)(H2,31,33,34,35,36)/t18-,19?,27?/m0/s1
InChIKey
GBLBJPZSROAGMF-SIYOEGHHSA-N
Compound name
N-[(1S)-1-[6-(4-fluoropyrazol-1-yl)pyridin-3-yl]ethyl]-1-methoxy-4-[4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]cyclohexane-1-carboxamide
Related CIDs

2D Structure

compound 2d structure
7
Annotation Hits

88
References

1285
Patents

533.2663 Da
Monoisotopic Mass

3.1
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 534.27358 219.8
[M+Na]+ 556.25552 225.2
[M-H]- 532.25902 226.2
[M+NH4]+ 551.30012 219.4
[M+K]+ 572.22946 217.4
[M+H-H2O]+ 516.26356 205.1
[M+HCOO]- 578.26450 231.1
[M+CH3COO]- 592.28015 224.3
[M+Na-2H]- 554.24097 216.9
[M]+ 533.26575 217.9
[M]- 533.26685 217.9
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe